0

542934

CBPL

img img img img
No Data Available

Chandra Bhagat Pharma Limited Share Price Update

As of the latest trading session, Chandra Bhagat Pharma Limited is trading at ₹33, up by ₹0.00 or 0.00% from its previous close. The stock has moved between ₹30.12 and ₹34.20 today. Over the past year, the stock has delivered a return of -41.07%. In the last month, it has returned 10.18%.

Investment Returns

Over 1 Month 10.18% Over 3 Months -19.51% Over 6 Months -17.52% Over 1 Year -41.07%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

Chandra Bhagat Pharma Limited fundamentals


  • Market cap (Cr) [-]
  • P/E Ratio (TTM) [-]
  • Beta [-]
  • Book Value / share [-]
  • Return on equity [-]%
  • EPS (TTM) [-]
  • Dividend yield [-]%
  • Net profit/quarter (Cr) [-]
info icon alternate text
  • Market cap (Cr) 24.90
  • P/E Ratio (TTM) 28.95
  • Beta -0.16
  • Book Value / share 39.72
  • Return on equity 2.41%
  • EPS (TTM) 0.94
  • Dividend yield [-]%
  • Net profit/quarter (Cr) 0.00
info icon alternate text

Chandra Bhagat Pharma Limited Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition
info-icon
Revenue
Net income
Particulars MAR 2025 (Values in Cr)
Revenue 86.72
Operating Expense 91.08
Net Profit 0.86
Net Profit Margin (%) 0.99
Earnings Per Share (EPS) 1.14
EBITDA 4.07
Effective Tax Rate (%) 26.49
Particulars MAR 2024 (Values in Cr)
Revenue 221.37
Operating Expense 230.45
Net Profit 1.53
Net Profit Margin (%) 0.69
Earnings Per Share (EPS) 2.03
EBITDA 4.28
Effective Tax Rate (%) 32.30
Particulars MAR 2023 (Values in Cr)
Revenue 119.67
Operating Expense 118.81
Net Profit 0.91
Net Profit Margin (%) 0.76
Earnings Per Share (EPS) 1.20
EBITDA 3.61
Effective Tax Rate (%) 22.41
Particulars MAR 2022 (Values in Cr)
Revenue 94.08
Operating Expense 94.60
Net Profit 0.80
Net Profit Margin (%) 0.85
Earnings Per Share (EPS) 1.06
EBITDA 4.30
Effective Tax Rate (%) 27.27
Particulars MAR 2021 (Values in Cr)
Revenue 70.70
Operating Expense 70.89
Net Profit 0.19
Net Profit Margin (%) 0.26
Earnings Per Share (EPS) 0.25
EBITDA 3.78
Effective Tax Rate (%) 32.14
Particulars MAR 2025 (Values in Cr)
Book Value / Share 39.72
ROE % 2.41
ROCE % 5.98
Total Debt to Total Equity 0.63
EBITDA Margin 4.43
Particulars MAR 2024 (Values in Cr)
Book Value / Share 38.45
ROE % 5.42
ROCE % 7.73
Total Debt to Total Equity 0.63
EBITDA Margin 1.94
Particulars MAR 2023 (Values in Cr)
Book Value / Share 36.42
ROE % 3.36
ROCE % 6.83
Total Debt to Total Equity 0.74
EBITDA Margin 3.03
Particulars MAR 2022 (Values in Cr)
Book Value / Share 35.35
ROE % 3.04
ROCE % 8.14
Total Debt to Total Equity 0.92
EBITDA Margin 4.74
Particulars MAR 2021 (Values in Cr)
Book Value / Share 34.30
ROE % 0.74
ROCE % 6.95
Total Debt to Total Equity 1.11
EBITDA Margin 5.88
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 0.66
Total Assets 101.53
Total Liabilities 101.53
Total Equity 29.96
Share Outstanding 0
Price to Book Ratio 1.32
Return on Assets (%) 0.84
Return on Capital (%) 1.69
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 4.96
Total Assets 101.80
Total Liabilities 101.80
Total Equity 29.00
Share Outstanding 0
Price to Book Ratio 2.47
Return on Assets (%) 1.50
Return on Capital (%) 3.37
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 6.43
Total Assets 60.58
Total Liabilities 60.58
Total Equity 27.47
Share Outstanding 0
Price to Book Ratio 2.66
Return on Assets (%) 1.49
Return on Capital (%) 1.95
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 5.68
Total Assets 72.46
Total Liabilities 72.46
Total Equity 26.67
Share Outstanding 0
Price to Book Ratio 3.22
Return on Assets (%) 1.09
Return on Capital (%) 1.67
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 2.82
Total Assets 71.78
Total Liabilities 71.78
Total Equity 25.87
Share Outstanding 0
Price to Book Ratio 1.15
Return on Assets (%) 0.26
Return on Capital (%) 0.37
Particulars MAR 2025 (Values in Cr)
Net Income 1.16
Cash from Operations -5.02
Cash from Investing -1.23
Cash from Financing 2.19
Net change in Cash -4.62
Free Cash Flow -3.82
Particulars MAR 2024 (Values in Cr)
Net Income 2.26
Cash from Operations 6.63
Cash from Investing -1.85
Cash from Financing -5.79
Net change in Cash -1.47
Free Cash Flow 8.91
Particulars MAR 2023 (Values in Cr)
Net Income 1.16
Cash from Operations 5.59
Cash from Investing -0.05
Cash from Financing -4.44
Net change in Cash 0.75
Free Cash Flow 5.96
Particulars MAR 2022 (Values in Cr)
Net Income 1.09
Cash from Operations 12.50
Cash from Investing 0.08
Cash from Financing -9.62
Net change in Cash 2.86
Free Cash Flow 12.60
Particulars MAR 2021 (Values in Cr)
Net Income 0.27
Cash from Operations 8.42
Cash from Investing 0.11
Cash from Financing -6.42
Net change in Cash 2.02
Free Cash Flow 8.44
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENT L 31.80 13.77 1.65 243.69 23.12 40.44
BLISS GVS PHARMA LTD 276.25 26.41 2.58 2922.42 105.05 280.20
CIPLA LTD 1309.90 22.25 3.21 105811.45 1165.55 1672.20
FERMENTA BIOTECH LIMITED 311.40 10.36 2.34 916.48 252.15 399.00
GLAXOSMITHKLINE PHARMA LT 2335.60 39.34 23.16 39566.47 2218.00 3515.95
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENT L 31.80 30.58 4.43 243.69 23.12 40.44
AMRUTANJAN HEALTH CARE LTD. 570.45 28.52 4.82 1649.21 490.00 789.95
ASTRAZENECA PHARMA INDIA LTD. 8217.20 98.75 25.71 20543.00 7630.00 10653.05
BLISS GVS PHARMA LTD 276.25 37.64 2.64 2922.42 105.05 280.20

Chandra Bhagat Pharma Limited shareholding pattern

Holding
26.98%
73.01%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

Chandra Bhagat Pharma Limited Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
33.00 0.00 redarrow
red-green-graph indicator
16 Bearish
0 Bullish
  • 5 Days 33.40
  • 26 Days 35.60
  • 10 Days 33.70
  • 50 Days 39.20
  • 12 Days 33.90
  • 100 Days 46.60
  • 20 Days 34.80
  • 200 Days 59.50
32.44 PIVOT
First Support 30.68 First Resistance 34.76 Second Support 28.36 Second Resistance 36.52 Third Support 26.60 Third Resistance 38.84
RSI 41.29 ADX 37.86 MACD -1.75 Williams % R -56.74 Commodity Channel Index (CCI) -60.31
Date 2026-04-27 Week 4500.00 Same Day 5000.00 Month 2636.00
1 Year -0.17 3 Year -0.66
Over 1 Month
10.18% down
Over 1 Year
-41.07% down
Over 3 Months
-19.51% down
Over 3 Years
-34.03% down
Over 6 Months
-17.52% down
Over 5 Years
-8.86% down

Chandra Bhagat Pharma Limited Corporate Actions

Top Gainers

Top Losers

Chandra Bhagat Pharma Limited Share Price

Chandra Bhagat Pharma Limited was incorporated as a Private Limited Company with the name 'Chandra Bhagat Pharma Private Limited' at Mumbai on March 10, 2003. Consequent upon the conversion of the Company from Private Limited Company to Public Limited Company, the name of the Company was changed to 'Chandra Bhagat Pharma Limited' on March 20, 2019.

The Company incorporated in March, 2003 by Mr. Hemant Bhagat and Late. Shree Chandravadan Bhagat. On April 1, 2003, the Company acquired the going concern business of M/s. Chandra Bhagat Corporation, partnership firm along with all its assets and liabilities. Consequently, the Company issued equity shares to respective partners of M/s. Chandra Bhagat Corporation upon the acquisition of going concern business.

Thereafter, the Promoter Mr. Hemant Bhagat continued the business on the footsteps of his father Late Shree Chandravadan Bhagat by focusing on marketing of life saving medicines like Antibiotics, Antineoplastic, Cardiovascular, Hormones etc. and set up the Company's marketing force to wider the product portfolio. Subsequently in 2004, the Promoters, Mr. Pranav Bhagat son of Mr. Hemant Bhagat, joined the business and decided to market the pharmaceuticals and special chemical products in domestic as well as in international market.

The Company is engaged in the business of marketing pharmaceutical critical care & health care products. For which it obtained necessary approvals from FDA for getting the formulations manufacture from contract manufacturers. At present, the Company has a wide range of products portfolio of pharmaceutical formulation including IV & IM range Injections, few tablets to cater the Domestic & Export Market. It has established presence in major therapeutic categories for formulations such as Anti-cancer (Oncology), Antibiotics, Anaesthesia, Hormones, Orthopaedic, Cardiac, Cardiovascular, Anti-fungal, Antiviral, Paediatrics, Cardiology, Nephrology, Neurology etc. It is engaged in promoting and marketing of Active Pharmaceuticals Ingredients (API's) in India.

The Company launched the IPO by issuing 20,00,000 equity shares of Rs 10 and raised Rs 10.2 crores through fresh issue on 6 February, 2020.

Parent organization Indian Private
NSE symbol [-]
Founded 2003
stock
Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Chandra Bhagat Pharma Ltd?

Answer Field

Chandra Bhagat Pharma Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 33.00 as on Apr 27 2026 12:00 AM.

What is the Market Cap of Chandra Bhagat Pharma Ltd Share?

Answer Field

The market cap of Chandra Bhagat Pharma Ltd for NSE ₹ 0.00 & for BSE ₹ 24.90 as on Apr 27 2026 12:00 AM.

What is the 52 Week High and Low of Chandra Bhagat Pharma Ltd?

Answer Field

The 52 Week High and Low of Chandra Bhagat Pharma Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 61.50 and ₹ 29.95.

What is 1 year return for Chandra Bhagat Pharma Ltd?

Answer Field

The 1 year returns on the stock has been -41.07%.

What is the P/E Ratio of Chandra Bhagat Pharma Ltd Share?

Answer Field

As on Apr 27 2026 12:00 AM the price-to-earnings (PE) ratio for Chandra Bhagat Pharma Ltd share is 28.95.

What is the PB ratio of Chandra Bhagat Pharma Ltd Share?

Answer Field

As on Apr 27 2026 12:00 AM, the price-to-book (PB) ratio for Chandra Bhagat Pharma Ltd share is 39.72.

How to Buy Chandra Bhagat Pharma Ltd Share?

Answer Field

You can trade in Chandra Bhagat Pharma Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Chandra Bhagat Pharma Ltd Share on Bajaj Broking App?

Answer Field

To buy Chandra Bhagat Pharma Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Chandra Bhagat Pharma Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image

Get Free Demat Account*

+91
close-img

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59
banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|